INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,502,000 | +14.8% | 269,677 | -1.8% | 0.01% | +28.6% |
| Q4 2021 | $14,372,000 | +79.2% | 274,580 | +27.6% | 0.01% | +40.0% |
| Q3 2021 | $8,022,000 | -16.7% | 215,195 | -8.8% | 0.01% | 0.0% |
| Q2 2021 | $9,628,000 | +142.8% | 235,871 | +101.9% | 0.01% | +150.0% |
| Q1 2021 | $3,965,000 | +10.0% | 116,854 | +3.1% | 0.00% | 0.0% |
| Q4 2020 | $3,604,000 | -8.8% | 113,324 | -26.4% | 0.00% | -33.3% |
| Q3 2020 | $3,952,000 | +26.5% | 154,031 | +26.5% | 0.00% | +50.0% |
| Q2 2020 | $3,125,000 | +99.0% | 121,726 | +19.1% | 0.00% | +100.0% |
| Q1 2020 | $1,570,000 | -11.4% | 102,170 | +97.7% | 0.00% | 0.0% |
| Q4 2019 | $1,773,000 | +464.6% | 51,679 | +23.0% | 0.00% | – |
| Q3 2019 | $314,000 | -53.3% | 42,012 | -18.9% | 0.00% | -100.0% |
| Q2 2019 | $673,000 | +23.9% | 51,833 | +16.2% | 0.00% | – |
| Q1 2019 | $543,000 | +196.7% | 44,610 | +176.9% | 0.00% | – |
| Q4 2018 | $183,000 | -60.0% | 16,109 | -23.4% | 0.00% | – |
| Q3 2018 | $457,000 | +24.9% | 21,043 | +1.6% | 0.00% | – |
| Q2 2018 | $366,000 | -67.7% | 20,712 | -61.5% | 0.00% | -100.0% |
| Q1 2018 | $1,132,000 | +304.3% | 53,789 | +177.7% | 0.00% | – |
| Q4 2017 | $280,000 | +18.6% | 19,370 | +29.5% | 0.00% | – |
| Q3 2017 | $236,000 | -84.4% | 14,954 | -83.9% | 0.00% | -100.0% |
| Q1 2017 | $1,511,000 | +457.6% | 92,971 | +418.1% | 0.00% | – |
| Q4 2016 | $271,000 | -36.5% | 17,944 | -36.0% | 0.00% | -100.0% |
| Q3 2016 | $427,000 | -55.3% | 28,040 | +13.8% | 0.00% | -50.0% |
| Q2 2016 | $956,000 | +252.8% | 24,633 | +152.3% | 0.00% | – |
| Q1 2016 | $271,000 | +11.1% | 9,763 | +114.9% | 0.00% | – |
| Q4 2015 | $244,000 | – | 4,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |